14-24316330-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001143919.3(LTB4R):āc.679A>Gā(p.Ile227Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000622 in 1,447,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001143919.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LTB4R | NM_001143919.3 | c.679A>G | p.Ile227Val | missense_variant | 2/2 | ENST00000345363.8 | |
LTB4R | NM_181657.3 | c.679A>G | p.Ile227Val | missense_variant | 2/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LTB4R | ENST00000345363.8 | c.679A>G | p.Ile227Val | missense_variant | 2/2 | 1 | NM_001143919.3 | P1 | |
LTB4R | ENST00000396782.2 | c.679A>G | p.Ile227Val | missense_variant | 2/2 | 1 | P1 | ||
LTB4R | ENST00000396789.4 | c.679A>G | p.Ile227Val | missense_variant | 2/2 | 1 | P1 | ||
LTB4R | ENST00000556141.1 | c.379A>G | p.Ile127Val | missense_variant | 2/2 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000130 AC: 3AN: 231056Hom.: 0 AF XY: 0.00000785 AC XY: 1AN XY: 127404
GnomAD4 exome AF: 0.00000622 AC: 9AN: 1447236Hom.: 0 Cov.: 32 AF XY: 0.00000834 AC XY: 6AN XY: 719370
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.679A>G (p.I227V) alteration is located in exon 2 (coding exon 1) of the LTB4R gene. This alteration results from a A to G substitution at nucleotide position 679, causing the isoleucine (I) at amino acid position 227 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at